Tetrahydrobiopterin restores endothelial function in hypercholesterolemia

Journal of Clinical Investigation

Volumn 99, Issue 1, 1997, Pages 41-46

  Stroes, Erik ^a   Kastelein, John ^b   Cosentino, Francesco ^c   Erkelens, Willem ^a   Wever, Robert ^a   Koomans, Hein ^a   Lüscher, Thomas ^c   Rabelink, Ton ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

atherosclerosis; hypercholesterolemia; L arginine; nitric oxide; tetrahydrobiopterin

Indexed keywords

ARGININE; CHOLESTEROL; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; OXYGEN RADICAL; TETRAHYDROBIOPTERIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MEAN ARTERIAL PRESSURE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

EID: 0031018510     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119131     Document Type: Article

References (49)

1. Anggard, E. 1994. Nitric oxide: mediator, murderer and medicine. Lancet. 343:1199-1206.
2. Luscher, T.F., and G. Noll. 1995. The pathogenesis of cardiovascular disease: role of the endothelium as target and mediator. Atherosclerosis. 188(Suppl.):S81-S90.
3. Stroes, E.S.G., H.A. Koomans, T.W.A. de Bruin, and T.J. Rabelink. 1995. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 346:467-471.
4. Creager, M., J.P. Cooke, M.E. Mendelsohn, S.J. Gallagher, S.M. Coleman, J. Loscalzo, and V.J. Dzau. 1990. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86:228-234.
5. Panza, J.A., C.E. Garcia, C.M. Kilcoyne, A.A. Quyyumi, and R.O. Cannon. 1995. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation. 91:1732-1738.
6. Johnstone, M.T., S.J. Creager, K.M. Scales, J.A. Cusco, B.K. Lee, and M.A. Creager. 1993. Impaired endothelium-dependent vasodilation in patients with insulin-dependent vasodilation. Circulation. 88:2510-2516.
7. Ting, H.T., F.K. Timimi, K.S. Boles, S.J. Creager, P. Ganz, and M.A. Creager. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97:22-28.
8. Heitzer, T., S. Yla-Herttuala, J. Luoma, S. Kurz, T. Munzel, H. Just, M. Olschewski, and H. Drexler. 1996. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolaemia. Circulation. 93:1346-1353.
9. Schmidt, K., E.R. Werner, B. Mayer, H. Wachter, and W.R. Kukovetz. 1992. Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem. J. 281:297-300.
10. Huie, R.E., and S. Padmaja. 1993. The reaction of NO with Superoxide. Free Radical Res. Commun. 18:195-199.
11. Minor, R.L., P.R. Myers, R. Guerra, J.N. Bates, and D.G. Harrison. 1990. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86:2109-2116.
12. Ohara, Y., T.E. Peterson, and D.G. Harrison. 1993. Hypercholesterolemia increases endothelial Superoxide anion production. J. Clin. Invest. 91: 2546-2551.
13. Pritchard, K.A., L. Groszek, D.M. Smalley, W.C. Sessa, M. Wu, P. Villalon, M.S. Wolin, and M.B. Stemerman. 1995. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of Superoxide anion. Circ. Res. 77:510-518.
14. Mayer, B., M. John, E.R. Werner, H. Wachter, G. Schultz, and E. Bohme. 1991. Brain nitric oxide synthase is a biopterin-and flavin-containing multifunctional oxido-reductase. FEBS Lett. 288:187-191.
15. 2+/ calmodulin dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J. 281:627-630.
16. Cosentino, F., and Z. Katusic. 1995. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 91: 139-144.
17. Drexler, H., A. Zeiher, K. Meinzer, and H. Just. 1991. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 338:1546-1550.
18. th ed. J.B. Stanbury, J.B. Wijngaarden, D.S. Frederickson, J.L. Goldstein, and M.S. Brown, editors. McGraw-Hill, New York. 672-712.
19. Chang, P.C., R. Verlinde, T.A. Bruning, and P. van Brummelen. 1988. A microcomputer-based R-wave triggered system for hemodynamic measurements in the forearm. Comput. Biol. Med. 18:157-163.
20. Calver, A., J. Collier, and P. Vallence. 1992. Inhibition and stimulation of nitric oxide in the human forearm bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90:2448-2454.
21. g-monomethyl-L-arginine resistant actions of acetylcholine in human forearm vasculature. Clin. Sci. 88:111-117.
22. Bruning, T.A., P.A. van Zwieten, G.J. Blauw, and P.C. Chang. 1994. No functional involvement of 5-hydroxytryptamine 1a receptors in nitric oxide dependent dilation caused by serotonin in the human forearm vascular bed. J. Cardiovasc. Pharmacol. 24:454-461.
23. Stroes, E.S.G., J.A. Joles, P.C. Chang, H.A. Koomans, and T.J. Rabelink. 1995. Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int. 48:544-550.
24. Chen, P.F., A. Tsai, and K.K. Wu. 1995. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem. Biophys. Res. Commun. 215:1119-1129.
25. Creager, M.A., S.J. Gallagher, X.J. Girerd, S.M. Coleman, V.J. Dzau, and J.P. Cooke. 1992. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90:1248-1253.
26. Benjamin, N., A. Calver, J. Collier, B. Robinson, P. Vallence, and D. Webb. 1995. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension (Dallas). 25:918-923.
27. Van Amsterdam, J.G.C., and J. Wemer. 1992. Tetrahydrobiopterin induces vasodilation via enhancement of cGMP level. Eur. J. Pharmacol. 215: 349-350.
28. Tsutsui, M., S. Milstein, and Z.S. Katusic. 1996. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ. Res. 79:336-342.
29. Davies, M.D., and S. Kaufman. 1993. Products of the tyrosine-dependent oxidation of tetrahydrobiopterin by rat liver phenylalanine hydroxylase. Arch. Biochem. Biophys. 304:9-16.
30. Gross, S.S., and R. Levi. 1992. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 36:25722-25729.
31. Cho, H.J., E. Martin, Q. Xie, and C. Nathan. 1995. Inducible nitric oxide synthase: identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin. Proc. Natl. Acad. Sci. USA. 92:11514-11518.
32. Schaffner, A., N. Blau, M. Schneemann, J. Steurer, C.S. Edgell, and G. Schoedon. 1994. Tetrahydrobiopterin as another EDRF in man. Biochem. Biophys. Res. Commun. 205:516-523.
33. Witteveen, C.F.B., J. Giovanelli, and S. Kaufman. 1996. Reduction of quinonoid dihydrobiopterin to tetrahydrobiopterin by nitric oxide synthase. J. Biol. Chem. 271:4143-4147.
34. Mayer, B., and E. Werner. 1995. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn-Schmiederberg's Arch. Pharmacol. 351:453-463.
35. Tayeh, M.A., and M.A. Marletta. 1989. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J. Biol. Chem. 264:19654-19658.
36. Klatt, P., K. Schmidt, D. Lehner, O. Glatter, H.P. Bachinger, and B. Mayer. 1995. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO (Eur. Mol. Biol. Organ.) J. 14:3687-3695.
37. Nathan, C., and Q. Xie. 1994. Nitric oxide synthases: roles, tolls and controls. Cell. 78:915-918.
38. Harrison, G., and Y. Ohara. 1995. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am. J. Cardiol. 75:75b-81b.
39. Rosenkranz-Weiss, P., W.C. Sessa, S. Milstein, S. Kaufman, C.A. Watson, and J.S. Pober. 1994. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest. 93:2236-2243.
40. Kume, N., M.I. Cybulsky, and M.A. Gimbrone. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1138-1144.
41. Gimbrone, M.A. 1995. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am. J. Cardiol. 75:67B-70B.
42. Hecker, M., W.C. Sessa, H.J. Harris, E. Anggard, and J.R. Vane. 1990. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. USA. 87:8612-8616.
43. Arnal, J.F., T. Munzel, R.C. Venema, N.L. James, C.L. Bai, W.E. Mitch, and D.G. Harrison. 1995. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J. Clin. Invest. 95:2565-2572.
44. Forstermann, U., E.I. Closs, J.S. Pollock, M. Nakane, P. Schwarz, I. Gath, and H. Kleinert. 1994. Nitric oxide synthase isoenzymes. Characterization, purification, molecular cloning, and functions. Hypertension (Dallas). 23: 1121-1131.
45. Nishimura, J.S., P. Martasek, K. McMillan, J.C. Salerno, Q. Liu, S.S. Gross, and B.S.S. Masters. 1995. Modular structure of neuronal nitric oxide synthase: localization of the arginine binding site and modulation by pterin. Biochem. Biophys. Res. Commun. 210:288-294.
46. Brand, M.P., S.J.R. Heales, J.M. Land, and J.B. Clark. 1995. Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse. J. Inher. Metab. Dis. 18:33-39.
47. Zeiher, A.M., H. Drexler, H. Wollschlager, and H. Just. 1991. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 83:391-401.
48. Quyyumi, A.A., N. Dakak, N.P. Andrews, S. Husain, S. Arora, D.M. Gilligan, and J.A. Panza. 1995. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J. Clin. Invest. 95: 1747-1753.
49. Reddy, K.G., R.N. Nair, H.M. Sheehan, and J. Hodgson. 1994. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J. Am. Coll. Cardiol. 23:833-843.